Showing results (1-10 of 1,626) with videos related to
Sort By:
Pageof 163
Journal of the American College of Cardiology|April 17, 2007
Atherosclerosis: the path from genomics to therapeuticsDavid T Miller, Paul M Ridker, Peter Libby, et al.The American Journal of Medicine|March 31, 2004
Inflammation and atherosclerosis: role of C-reactive protein in risk assessmentPeter Libby, Paul M RidkerTrends in Cardiovascular Medicine|October 17, 2020
COVID-19 - A vascular diseaseHasan K Siddiqi, Peter Libby, Paul M RidkerNature|May 20, 2011
Progress and challenges in translating the biology of atherosclerosisPeter Libby, Paul M Ridker, Göran K HanssonJournal of the American College of Cardiology|November 28, 2009
Inflammation in atherosclerosis: from pathophysiology to practicePeter Libby, Paul M Ridker, Göran K Hansson, et al.American Heart Journal|October 11, 2011
Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)Paul M Ridker, Tom Thuren, Andrew Zalewski, et al.European Heart Journal|September 11, 2019
Residual inflammatory risk associated with interleukin-18 and interleukin-6 after successful interleukin-1β inhibition with canakinumab: further rationale for the development of targeted anti-cytokine therapies for the treatment of atherothrombosisPaul M Ridker, Jean G MacFadyen, Tom Thuren, et al.The American Journal of Cardiology|July 6, 2010
Relation of baseline high-sensitivity C-reactive protein level to cardiovascular outcomes with rosuvastatin in the Justification for Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)Paul M Ridker, Jean MacFadyen, Peter Libby, et al.Annals of Human Genetics|March 1, 2018
Lack of Association Between Genetic Variation in 9 Innate Immunity Genes and Baseline CRP LevelsPiotr Kozlowski, David T Miller, Robert Y L Zee, et al.Pageof 163